Whitney Bollenbacher, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 531 E Tully St, Convoy, OH 45832 Phone: 419-749-9100 |
News Archive
Personalized medicine - improving the fit between patient and treatment - has become a major focus of research in fields from cancer treatment to the psychopharmacology of mental disorders. Genetic studies have suggested that an individual's genetic makeup renders him either more or less sensitive to stressful social environments - but can an individual's unique genotype also determine the effectiveness of preventative or therapeutic behavioral interventions?
Boehringer Ingelheim presented results of a drug interaction study that found Aggrenox (aspirin/extended-release dipyridamole), an antiplatelet medication, is not affected by the co-administration of omeprazole, a proton pump inhibitor (PPI), frequently used to treat several gastrointestinal conditions. These data were presented at the International Stroke Conference (ISC) in New Orleans.
Kaiser Health News staff writer Jessica Marcy recently spoke with Dan Hawkins, the association's senior vice president, about the future and finances of community health centers and their evolving budgets.
NeurogesX, Inc. announced today that Qutenza® (capsaicin) 8% patch, the first and only product containing prescription-strength capsaicin, is now available. Clinical studies have shown that a single one-hour Qutenza application can provide three months relief from pain associated with postherpetic neuralgia, the nerve pain that can occur after shingles.
A new study on the preprint server medRxiv* discusses the predictive value of single symptom-based screening to confirm pediatric SARS-CoV-2 cases.
› Verified 5 days ago